Evidence map›Paper›PMID 26453170›Full record

ArticleJournal of drug targeting2015

Long-circulating Janus nanoparticles made by electrohydrodynamic co-jetting for systemic drug delivery applications.

Sahar Rahmani, Carlos H Villa, Acacia F Dishman, Marika E Grabowski, Daniel C Pan, Hakan Durmaz, Asish C Misra, Laura Colón-Meléndez, Michael J Solomon, Vladimir R Muzykantov and 1 more

Abstract read
In one paragraph

Article in Journal of drug targeting, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Protein Nanoparticles: Uniting the Power of Proteins with Engineering Design Approaches.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Review
  5. Microfluidic Methods in Janus Particle Synthesis.International journal of nanomedicine · 2022
    Review
  6. Review
  7. Review
  8. Janus particles: recent advances in the biomedical applications.International journal of nanomedicine · 2019
    Review
  9. Engineering of nanoparticle size via electrohydrodynamic jetting.Bioengineering & translational medicine · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sahar Rahmania Biointerfaces Institute, University of Michigan , Ann Arbor , MI , USA .
Carlos H Villad Department of Pharmacology , University of Pennsylvania , Philadelphia , PA , USA , and.
Acacia F Dishmana Biointerfaces Institute, University of Michigan , Ann Arbor , MI , USA .
Marika E Grabowskia Biointerfaces Institute, University of Michigan , Ann Arbor , MI , USA .
Daniel C Pand Department of Pharmacology , University of Pennsylvania , Philadelphia , PA , USA , and.
Hakan Durmaza Biointerfaces Institute, University of Michigan , Ann Arbor , MI , USA .
Asish C Misraa Biointerfaces Institute, University of Michigan , Ann Arbor , MI , USA .
Laura Colón-Meléndeza Biointerfaces Institute, University of Michigan , Ann Arbor , MI , USA .
Michael J Solomona Biointerfaces Institute, University of Michigan , Ann Arbor , MI , USA .
Vladimir R Muzykantovd Department of Pharmacology , University of Pennsylvania , Philadelphia , PA , USA , and.
Joerg Lahanna Biointerfaces Institute, University of Michigan , Ann Arbor , MI , USA .

Funding

Tissue Engineering and RegenerationT32DE007057 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID H. KOHN · 1985 to 2026
$17.3M
Training in Molecular Therapeutics for Pediatric CardiologyT32HL007915 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI Robert J Levy, JOSEPH W ROSSANO · 1999 to 2026
$13.4M
TRANSFUSION MEDICINE RESEARCH TRAINING PROGRAMT32HL007775 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI SIEGEL, DONALD LAWRENCE · 1993 to 2023
$2.8M
Drug delivery by carrier erythrocytesR01HL121134 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MUZYKANTOV, VLADIMIR R · 2014 to 2017
$2.6M
NHLBI NIH HHS R01 HL121134NHLBI NIH HHS T32 HL007775NHLBI NIH HHS T32 HL007915NIDCR NIH HHS DE00007057-36NIDCR NIH HHS T32 DE007057
6 · The paper itself

Abstract

backgroundNanoparticles with controlled physical properties have been widely used for controlled release applications. In addition to shape, the anisotropic nature of the particles can be an important design criterion to ensure selective surface modification or independent release of combinations of drugs. PURPOSE: Electrohydrodynamic (EHD) co-jetting is used for the fabrication of uniform anisotropic nanoparticles with individual compartments and initial physicochemical and biological characterization is reported.

methodsEHD co-jetting is used to create nanoparticles, which are characterized at each stage with scanning electron microscopy (SEM), structured illumination microscopy (SIM), dynamic light scattering (DLS) and nanoparticle tracking analysis (NTA). Surface immobilization techniques are used to incorporate polyethylene glycol (PEG) and I(125) radiolabels into the nanoparticles. Particles are injected in mice and the particle distribution after 1, 4 and 24 hours is assessed. RESULTS AND DISCUSSION: Nanoparticles with an average diameter of 105.7 nm are prepared by EHD co-jetting. The particles contain functional chemical groups for further surface modification and radiolabeling. The density of PEG molecules attached to the surface of nanoparticles is determined to range between 0.02 and 6.04 ligands per square nanometer. A significant fraction of the nanoparticles (1.2% injected dose per mass of organ) circulates in the blood after 24 h.

conclusionEHD co-jetting is a versatile method for the fabrication of nanoparticles for drug delivery. Circulation of the nanoparticles for 24 h is a pre-requisite for subsequent studies to explore defined targeting of the nanoparticles to a specific anatomic site.

Indexed as

Drug Delivery SystemsAnimalsAnisotropyDelayed-Action PreparationsDynamic Light ScatteringHydrodynamicsIodine RadioisotopesMaleMiceMice, Inbred C57BLMicroscopy, Electron, ScanningNanoparticlesParticle SizePolyethylene GlycolsPolymersTechnology, PharmaceuticalDelayed-Action PreparationsIodine RadioisotopesPolyethylene GlycolsPolymersBiodistribution studieselectrosprayingfunctional polymersJanus nanoparticlesligand density

Identifiers

PMID26453170
PMCPMC4760101

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.